96 related articles for article (PubMed ID: 16136765)
1. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
2. An Update on Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria.
Miniello A; Casella R; Loverre T; Aloia D; Di Bona D; Nettis E
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):885-895. PubMed ID: 37691219
[TBL] [Abstract][Full Text] [Related]
3. Angioedema without urticaria after recent initiation of celecoxib.
Jasti VV; Anderson J; Abdujelil I
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37739445
[TBL] [Abstract][Full Text] [Related]
4. Accurate phenotyping of cross-reactive hypersensitivity is essential to shed light on the underlying mechanisms in NSAID-induced urticaria/angioedema.
Cornejo-García JA; Núñez R; Torres MJ; Doña I
J Allergy Clin Immunol; 2023 Mar; 151(3):803. PubMed ID: 36543695
[No Abstract] [Full Text] [Related]
5. Risk of hospitalization for angio-oedema among users of newer COX-2 selective inhibitors and other nonsteroidal anti-inflammatory drugs.
Downing A; Jacobsen J; Sorensen HT; McLaughlin JK; Johnsen SP
Br J Clin Pharmacol; 2006 Oct; 62(4):496-501. PubMed ID: 16939524
[TBL] [Abstract][Full Text] [Related]
6. Alternative Drug Safety in Children with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
Aytekin Güvenir F; Turgay Yağmur İ; Dibek Mısırlıoğlu E
Int Arch Allergy Immunol; 2024 May; ():1-7. PubMed ID: 38815557
[TBL] [Abstract][Full Text] [Related]
7. Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema.
Salle R; Skayem C; Longvert C; Castagna J; Soria A; Funck-Brentano E
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):257-258. PubMed ID: 37813300
[No Abstract] [Full Text] [Related]
8. Angioedema without urticaria after recent initiation of celecoxib.
Jasti VV; Anderson J; Abdujelil I
Drug Ther Bull; 2024 Jun; ():. PubMed ID: 38844069
[No Abstract] [Full Text] [Related]
9. Author's response.
Johnson WD
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):525. PubMed ID: 28390591
[No Abstract] [Full Text] [Related]
10. Parallel remission of nonsteroidal anti-inflammatory drugs-exacerbated cutaneous reactions and chronic spontaneous urticaria.
Sánchez J; Diez S; Lopez JF
J Allergy Clin Immunol Pract; 2024 May; ():. PubMed ID: 38763464
[No Abstract] [Full Text] [Related]
11. Urticaria and angioedema in Estonia, Iceland and Sweden.
Heldin J; Malinovschi A; Hägg SA; Gíslason T; Benediktsdóttir B; Movérare R; Hallgren J; Molin M; Jogi R; Janson C
Clin Exp Allergy; 2024 Mar; 54(3):228-230. PubMed ID: 38191145
[No Abstract] [Full Text] [Related]
12. A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS.
Ashubu OF; Ademola AD; Asinobi AO
Ann Ib Postgrad Med; 2016 Jun; 14(1):41-43. PubMed ID: 27721685
[TBL] [Abstract][Full Text] [Related]
13. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
Muratore L; Ventura M; Calogiuri G; Calcagnile F; Quarta E; Muratore M; Ferrannini A
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
[TBL] [Abstract][Full Text] [Related]
15. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
16. Safety of etoricoxib in patients with reactions to NSAIDs.
Quercia O; Emiliani F; Foschi FG; Stefanini GF
J Investig Allergol Clin Immunol; 2008; 18(3):163-7. PubMed ID: 18564626
[TBL] [Abstract][Full Text] [Related]
17. Anaphylaxis to Etoricoxib.
Couto M; López-Salgueiro R; Gaspar Â
J Investig Allergol Clin Immunol; 2018 Apr; 28(2):135-136. PubMed ID: 29661743
[No Abstract] [Full Text] [Related]
18. NSAID-sensitive antihistamine-induced urticaria/angioedema.
Cimbollek S; Ortega Camarero M; Avila R; Quiralte J; Prados M
J Investig Allergol Clin Immunol; 2011; 21(6):488-90. PubMed ID: 21995184
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity.
Loh W; Lim HH; Rao R; Goh A; Ong LX; Chiang WC
Asia Pac Allergy; 2015 Jan; 5(1):40-6. PubMed ID: 25653919
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients.
Malskat WS; Knulst AC; Bruijnzeel-Koomen CA; Röckmann H
Clin Transl Allergy; 2013 Jun; 3(1):20. PubMed ID: 23799898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
